海尔生物：累计回购公司股份2590257股

Group 1 - The core point of the article is that Haier Biomedical announced a share buyback plan, indicating a strategic move to enhance shareholder value [2] - As of October 31, 2025, the company has repurchased a total of 2,590,257 shares [2] - This repurchase represents approximately 0.8147% of the company's total share capital of 317,952,508 shares [2]